Martine van Vugt

Director/Board Member at SCANDION ONCOLOGY A/S

71 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Johnny Stilou	M	57	SCANDION ONCOLOGY A/S	3 years
Jan van de Winkel	M	63	GENMAB A/S	25 years
Deirdre Connelly	F	63	GENMAB A/S	7 years
Martin Møller	M	49	SCANDION ONCOLOGY A/S	3 years
Jørgen Vilhelm Bardenfleth	M	69	SCANDION ONCOLOGY A/S	6 years
Tahamtan Ahmadi	M	51	GENMAB A/S	7 years
Keld Flintholm Jørgensen	M	53	SCANDION ONCOLOGY A/S	2 years
Peter Michael Vestlev	M	-	SCANDION ONCOLOGY A/S	-
Jan Stenvang	M	-	SCANDION ONCOLOGY A/S	7 years
Anthony Pagano	M	46	GENMAB A/S	17 years
Susan Coles	F	58	TME PHARMA N.V.	3 years
Paolo Augusto Paoletti	M	73	GENMAB A/S	9 years
Pernille Erenbjerg	F	57	GENMAB A/S	9 years
Marisol Peron	F	-	GENMAB A/S	5 years
Maarten Ligtenberg	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Elizabeth O'Farrell	F	59	GENMAB A/S	2 years
Maurizio PetitBon	M	76	TME PHARMA N.V.	8 years
Karen Ophoff	F	-	TME PHARMA N.V.	23 years
Alejandra Maria Mørk	M	62	SCANDION ONCOLOGY A/S	2 years
Cornelis Alexander Izeboud	M	53	TME PHARMA N.V.	4 years
Rolf K. Hoffmann	M	63	GENMAB A/S	8 years
Aram Andrew Mangasarian	M	54	TME PHARMA N.V.	14 years
Ewelina Staniuk	F	-	TME PHARMA N.V.	6 years
Nicky Vogels	F	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Takahiro Hamatani	M	50	GENMAB A/S	2 years
Martin Schultz	M	49	GENMAB A/S	2 years
Heike Balzer	M	-	TME PHARMA N.V.	24 years
Christopher Cozic	M	46	GENMAB A/S	-
Allard Kaptein	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Anthony Mancini	M	53	GENMAB A/S	4 years
Mijke Zachariasse	M	51	GENMAB A/S	5 years
Morten Nissen	M	-	SCANDION ONCOLOGY A/S	-
Judith Klimovsky	M	67	GENMAB A/S	7 years
Shobhit Dhawan	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Birgitte Stephensen	F	63	GENMAB A/S	22 years
Andrew Carlsen	M	-	GENMAB A/S	5 years
François Martelet	M	64	SCANDION ONCOLOGY A/S	1 years
Anders Gersel Pedersen	M	73	GENMAB A/S	21 years
Lars Damstrup	M	-	SCANDION ONCOLOGY A/S	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Daniel John Bruno	M	45	GENMAB A/S	5 years
Bo Rode Hansen	M	-	SCANDION ONCOLOGY A/S	2 years
Michael Blair Widmer	M	76	GENMAB A/S	11 years
Mats Gunnar Pettersson	M	78	GENMAB A/S	7 years
Bo Kruse	M	52	GENMAB A/S	8 years
Christina Hahner	F	-	GENMAB A/S	-
Jonathan Peacock	M	66	GENMAB A/S	1 years
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	54	GENMAB A/S	-
Michael K. Bauer	M	60	GENMAB A/S	14 years
Helle Husted	F	-	GENMAB A/S	-
Rachel Curtis Gravesen	F	55	GENMAB A/S	8 years
Nils Aage Brünner	M	72	SCANDION ONCOLOGY A/S	-
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 years
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 years
Bertram Köhler	M	53	TME PHARMA N.V.	5 years
Lisa N. Drakeman	M	70	GENMAB A/S	11 years
Burt Malkiel	M	90	GENMAB A/S	11 years
Antonius Theodorus M Wilderbeek	M	74	GENMAB A/S	2 years
Maj Hedtjärn	M	-	SCANDION ONCOLOGY A/S	1 years
Joseph deBethizy	M	74	TME PHARMA N.V.	7 years
Eva Ehrnrooth	M	57	GENMAB A/S	2 years
Suba Krishnan	M	59	GENMAB A/S	1 years
Richard Gordon Hibbert	M	44	GENMAB A/S	3 years
Peter Storm Kristensen	M	49	GENMAB A/S	-
Rima Bawarsh Nassar	M	70	GENMAB A/S	-
Steen Lisby	M	60	GENMAB A/S	9 years
Joris Wilms	M	50	GENMAB A/S	2 years
Christian Vinding Thomsen	M	-	SCANDION ONCOLOGY A/S	5 years
Nicklas Lindland Roest	F	39	SCANDION ONCOLOGY A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 years
Irwin Lerner	M	93	GENMAB A/S	-
Alfredo Zurlo	M	-	SCANDION ONCOLOGY A/S	-
Rikke Glahn Ren	F	-	GENMAB A/S	-
Barry Littlejohns	M	58	GENMAB A/S	-
Hanne Damgaard Jensen	F	-	GENMAB A/S	8 years
Paul W. H. I. Parren	M	60	GENMAB A/S	16 years
Annarie Lyles	M	63	GENMAB A/S	-
David Andrew Eatwell	M	63	GENMAB A/S	12 years
Joseph Fred Yospe	M	66	GENMAB A/S	2 years
Michael Wolff Jensen	M	53	GENMAB A/S	3 years
Claus Juan Møller-San Pedro	M	62	GENMAB A/S	9 years
Ernst H. Schweizer	M	-	GENMAB A/S	-
Bryan Jennings	M	-	TME PHARMA N.V.	1 years
Gregory Weaver	M	68	TME PHARMA N.V.	1 years
Mads Aaboe Jensen	M	-	SCANDION ONCOLOGY A/S	-

Statistics

Country	Connections	% of total
Denmark	71	82.56%
Germany	11	12.79%
Netherlands	4	4.65%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections